Grupo de Hematología Experimental - VHIO
Vol. 1 Núm. 1 (2021): 35 Congreso Nacional SERAM | Seram
Ruth Barrena Puertas | Hospital Universitario Quirónsalud Madrid
Cuadro Médico Adeslas Madrid 2021 by OAC Adeslas Madrid - Torrelodones - Issuu
Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases | Radiology
Dra. Ruth Barrena Puertas opiniones - Internista Pozuelo De Alarcón - Doctoralia
Equipo Médico | Hospital Universitario Quirónsalud Madrid
RevistaGHQnº12 by Quirónsalud - Issuu
Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and r
Panorama de las tecnologías para el tratamiento de desechos infecciosos y punzocortantes en los centros de salud
Tropical forest cover change in the 1990s and options for future monitoring | Philosophical Transactions of the Royal Society B: Biological Sciences
COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus - hdl:20.500.12010/10692
Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and r
Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: A retrospective ...
Revista GHQ nº11 by Quirónsalud - Issuu
Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and r
Annual Report
Tropical forest cover change in the 1990s and options for future monitoring | Philosophical Transactions of the Royal Society B: Biological Sciences
ANNUAL REPORT
Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: A retrospective ...
